What is he best known for?
The fields of study he is best known for:
- Immune system
- Gene
- Cancer
His primary areas of study are Immunology, Immune system, Antibody, Antigen and Virology.
Immunology is often connected to Cell biology in his work.
His Immune system study deals with Adjuvant intersecting with Circumsporozoite protein, Immune checkpoint, MART-1 Antigen and CCL18.
Tibor Keler mostly deals with Monoclonal antibody in his studies of Antibody.
The Cross-presentation research Tibor Keler does as part of his general Antigen study is frequently linked to other disciplines of science, such as Mannose receptor, therefore creating a link between diverse domains of science.
His work in Virology addresses subjects such as Dendritic cell, which are connected to disciplines such as Immunoglobulin G and Viral vector.
His most cited work include:
- Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117 (459 citations)
- Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma (400 citations)
- HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption (262 citations)
What are the main themes of his work throughout his whole career to date?
Tibor Keler focuses on Immunology, Antibody, Cancer research, Immune system and Monoclonal antibody.
His Antibody research integrates issues from T cell, CD70, Receptor and Virology.
His studies deal with areas such as Agonist, Cytotoxic T cell, Blockade and Lymphoma as well as Cancer research.
As part of his studies on Immune system, Tibor Keler frequently links adjacent subjects like Adjuvant.
His Monoclonal antibody study incorporates themes from Molecular biology, Genetically modified mouse, Transgene and Fc receptor.
In general Antigen, his work in Cross-presentation is often linked to Mannose receptor linking many areas of study.
He most often published in these fields:
- Immunology (40.99%)
- Antibody (37.27%)
- Cancer research (33.54%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (33.54%)
- Immune system (32.92%)
- T cell (19.25%)
In recent papers he was focusing on the following fields of study:
Tibor Keler spends much of his time researching Cancer research, Immune system, T cell, Antibody and CD8.
The various areas that Tibor Keler examines in his Cancer research study include CD40, Agonist, Receptor, Blockade and Monoclonal antibody.
His Immune system research focuses on subjects like Cytokine, which are linked to Pharmacology.
The concepts of his Antibody study are interwoven with issues in CD70 and Pharmacodynamics.
His Immunotherapy study is concerned with the field of Immunology as a whole.
His work carried out in the field of Immunology brings together such families of science as Stimulation and Genetically modified organism.
Between 2017 and 2021, his most popular works were:
- PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell-Driven Antitumor Immunity. (40 citations)
- Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial. (24 citations)
- Conventional Dendritic Cells Impair Recovery after Myocardial Infarction. (21 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Gene
- Cancer
Tibor Keler mainly investigates Cancer research, Immunology, CD8, CD40 and Immune system.
His Cancer research research is multidisciplinary, relying on both Agonist, Blockade, Priming and Cancer immunotherapy.
His research in Blockade focuses on subjects like Antibody, which are connected to Proinflammatory cytokine.
His Immunology study frequently intersects with other fields, such as Ligand.
As part of the same scientific family, he usually focuses on CD40, concentrating on T cell and intersecting with Myeloid.
Tibor Keler studies Immune system, focusing on Immunotherapy in particular.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
